Venus Remedies gets approval to market Meropenem in Spain
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Meropenem
Venus gets marketing authorisation for Meropenem
Meropenem is a last-resort drug of the carbapenem class of antibiotics which is used in intensive care units (ICUs) of hospitals